Bing Shiou Yang

Title: The Innovative Contributions of Bing Shiou Yang

Introduction

Bing Shiou Yang is a notable inventor based in Southbury, CT (US). He has made significant contributions to the field of pharmacology through his innovative research and development of new compounds. His work focuses on addressing critical health issues, particularly those related to metabolic diseases.

Latest Patents

Bing Shiou Yang holds a patent for "Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline." This invention relates to compounds defined by a specific formula, which possess valuable pharmacological activity. The compounds are particularly noted for their ability to inhibit 11β-hydroxysteroid dehydrogenase (HSD) 1, making them suitable for the treatment and prevention of diseases influenced by this enzyme, such as type 2 diabetes, obesity, and dyslipidemia. He has 1 patent to his name.

Career Highlights

Bing Shiou Yang is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research in pharmacology. His work has been instrumental in developing new therapeutic options for patients suffering from metabolic disorders.

Collaborations

Throughout his career, Bing has collaborated with esteemed colleagues, including Matthias Eckhardt and Sandra Sick. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Bing Shiou Yang's contributions to the field of pharmacology through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to pave the way for advancements in the treatment of metabolic diseases.